Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode

Sacha Bodin, Lisa C. Peuker, Emmanuelle Jestin, Isabel D. Alves, Valérie Velasco, Imade Ait-Arsa, Romain Schollhammer, Frédéric Lamare, Delphine Vimont, Gaétan MacGrogan, Elif Hindié, Annette G. Beck-Sickinger, Clément Morgat
Bioconjugate Chem.. 2023-08-09; 34(11): 2014-2021
DOI: 10.1021/acs.bioconjchem.3c00313


Lire sur PubMed

https://www.bordeaux-neurocampus.fr/12727

---

Bodin S(1)(2), Peuker LC(3), Jestin E(4), Alves ID(5), Velasco V(6)(7), Ait-Arsa
I(4), Schollhammer R(1)(2), Lamare F(2), Vimont D(2), MacGrogan G(6)(7), Hindié
E(1)(2)(8), Beck-Sickinger AG(3), Morgat C(1)(2).

Author information:
(1)Department of Nuclear Medicine, University Hospital of Bordeaux, F-33076
Bordeaux, France.
(2)CNRS, EPHE, INCIA UMR 5287, University of Bordeaux, F-33400 Talence, France.
(3)Institute of Biochemistry, Faculty of Life Sciences, Leipzig University,
Brüderstr. 34, 04103 Leipzig, Germany.
(4)GIP CYROI – Cyclotron Réunion Océan Indien, F-97490 Saint Clotilde, France.
(5)CNRS UMR 248, Institute of Chemistry & Biology of Membranes & Nano-objects
(CBMN), University of Bordeaux, F-33600 Pessac, France.
(6)Surgical Pathology Unit, Department of Biopathology, Institut Bergonié,
F-33076 Bordeaux, France.
(7)ACTION U1218, INSERM, F-33076 Bordeaux, France.
(8)Institut Universitaire de France, F-75000 Paris, France.

Auteurs Bordeaux Neurocampus